LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
MUSC Foundation for Research Development welcomes Art Pappas to board
News | 04. 23. 2014
Pappas to share venture capital expertise in pharmaceutical and life sciences industries
CHARLESTON, SC - April 23, 2014 - The Medical University of South Carolina Foundation for Research Development (FRD) has announced that venture capitalist Art Pappas has joined the organization’s Board of Directors, effective immediately.
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.